SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 131 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,245,000 | +9.6% | 91,906 | -0.4% | 0.00% | 0.0% |
| Q3 2016 | $1,136,000 | +12.0% | 92,311 | -0.1% | 0.00% | 0.0% |
| Q2 2016 | $1,014,000 | +3.8% | 92,447 | +3.4% | 0.00% | 0.0% |
| Q1 2016 | $977,000 | -36.6% | 89,415 | +0.2% | 0.00% | -50.0% |
| Q4 2015 | $1,542,000 | -12.5% | 89,206 | +0.6% | 0.00% | 0.0% |
| Q3 2015 | $1,762,000 | +19.1% | 88,666 | -1.5% | 0.00% | 0.0% |
| Q2 2015 | $1,479,000 | +83.7% | 90,012 | +74.0% | 0.00% | +100.0% |
| Q1 2015 | $805,000 | +10.0% | 51,718 | +0.9% | 0.00% | 0.0% |
| Q4 2014 | $732,000 | +117.2% | 51,282 | -1.0% | 0.00% | – |
| Q3 2014 | $337,000 | -1.7% | 51,805 | +4.1% | 0.00% | – |
| Q2 2014 | $343,000 | +27.0% | 49,764 | +32.0% | 0.00% | – |
| Q1 2014 | $270,000 | -24.8% | 37,707 | -1.1% | 0.00% | -100.0% |
| Q4 2013 | $359,000 | +49.6% | 38,143 | -0.9% | 0.00% | – |
| Q3 2013 | $240,000 | +4.3% | 38,500 | +10.4% | 0.00% | – |
| Q2 2013 | $230,000 | – | 34,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,304,376 | $23,414,000 | 7.30% |
| Kassirer Asset Management Corp | 291,784 | $5,238,000 | 5.39% |
| First Trust Capital Management L.P. | 637,578 | $11,445,000 | 2.19% |
| NEXTHERA CAPITAL LP | 510,486 | $9,163,000 | 1.69% |
| HAVENS ADVISORS LLC | 100,000 | $1,795,000 | 1.35% |
| Piermont Capital Management Inc. | 172,980 | $3,105,000 | 1.02% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 674,446 | $12,106,000 | 0.97% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 1,495,600 | $26,845,000 | 0.96% |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 200,000 | $3,590,000 | 0.87% |
| BOOTHBAY FUND MANAGEMENT, LLC | 332,075 | $5,961,000 | 0.87% |